The impact of timing of antimicrobial therapy on outcome and mortality in severe sepsis and septic shock

Ahmed Najah A Zahra

doi:10.53730/ijhs.v8nS1.14895

Authors

Ahmed Najah A. Zahra
salameeahmed@gmail.com
Senior Specialist Registrar, Intensive Care Department, Dubai Hospital

Keywords:

antimicrobial therapy, septic shock, mortality in severe sepsis

Abstract

Even though new antimicrobial treatments have been available for over 60 years, the fatality rate from septic shock has not decreased. Evolutionary pressure on microbial pathogens has, as expected, led to selection towards resistant species as a consequence of the creation of ever more broad-spectrum and strong antimicrobials. The ineffectiveness of antibiotic treatment of septic shock un the decades that followed may have been a result of this phenomena. The treatment of septic shock has traditionally focused on resuscitative measures. The management of these serious illnesses has not prioritised the prompt provision of effective antibiotic treatment.

Downloads

Download data is not yet available.

References

Rhee, C., Chiotos, K., Cosgrove, S. E., Heil, E. L., Kadri, S. S., Kalil, A. C., et al. (2021). Infectious Diseases Society of America position paper: recommended revisions to the national severe sepsis and septic shock early management bundle (SEP-1) sepsis quality measure. Clinical Infectious Diseases, 72(4), 541–552.

Pak, T. R., Rhee, C., Klompas, M. (2022). Timing and spectrum of antibiotic treatment for suspected sepsis and septic shock: why so controversial? Infectious Disease Clinics of North America, 36(4), 719–733.

Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., et al. (2021). Executive summary: surviving sepsis campaign: international guidelines for the management of sepsis and septic shock 2021. Critical Care Medicine, 49(11), 1974–1982.

Jouffroy, R., Gilbert, B., Tourtier, J. P., Bloch-Laine, E., Ecollan, P., Bounes, V., et al. (2021). Impact of prehospital antibiotic therapy on septic shock mortality. Prehospital Emergency Care, 25(3), 317–324.

Seok, H., Jeon, J. H., Park, D. W. (2020). Antimicrobial therapy and antimicrobial stewardship in sepsis. Infection & Chemotherapy, 52(1), 19.

Vishalashi, S. M. G., Gupta, P., Verma, P. K. (2021). Serum procalcitonin as a biomarker to determine the duration of antibiotic therapy in adult patients with sepsis and septic shock in intensive care units: A prospective study. Indian Journal of Critical Care Medicine: Peer-Reviewed, Official Publication of Indian Society of Critical Care Medicine, 25(5), 507

Routsi, C., Gkoufa, A., Arvaniti, K., Kokkoris, S., Tourtoglou, A., Theodorou, V., et al. (2020). De-escalation of antimicrobial therapy in ICU settings with high prevalence of multidrug-resistant bacteria: a multicentre prospective observational cohort study in patients with sepsis or septic shock. Journal of Antimicrobial Chemotherapy, 75(12), 3665–3674.

Rüddel, H., Thomas-Rüddel, D. O., Reinhart, K., Bach, F., Gerlach, H., Lindner, M., et al. (2022). Adverse effects of delayed antimicrobial treatment and surgical source control in adults with sepsis: results of a planned secondary analysis of a cluster-randomized controlled trial. Critical Care, 26(1), 51.

Stephen, A. H., Montoya, R. L., Aluisio, A. R. (2020). Sepsis and septic shock in low-and middle-income countries. Surgical Infections, 21(7), 571–578.

Landersdorfer, C. B., Nation, R. L. (2021). Key challenges in providing effective antibiotic therapy for critically ill patients with bacterial sepsis and septic shock. Clinical Pharmacology & Therapeutics, 109(4), 892–904.

Rothrock, S. G., Cassidy, D. D., Barneck, M., Schinkel, M., Guetschow, B., Myburgh, C., et al. (2020). Outcome of immediate versus early antibiotics in severe sepsis and septic shock: a systematic review and meta-analysis. Annals of Emergency Medicine, 76(4), 427–441.

Nauclér, P., Huttner, A., Van Werkhoven, C. H., Singer, M., Tattevin, P., Einav, S., et al. (2021). Impact of time to antibiotic therapy on clinical outcome in patients with bacterial infections in the emergency department: implications for antimicrobial stewardship. Clinical Microbiology and Infection, 27(2), 175–181.

Im, Y., Kang, D., Ko, R.-E., Lee, Y. J., Lim, S. Y., Park, S et al. (2022). Time-to-antibiotics and clinical outcomes in patients with sepsis and septic shock: a prospective nationwide multicenter cohort study. Critical Care, 26, 1–10.

Sankar, J., Garg, M., Ghimire, J. J., Sankar, M. J., Lodha, R., Kabra, S. K. (2021). Delayed administration of antibiotics beyond the first hour of recognition is associated with increased mortality rates in children with sepsis/severe sepsis and septic shock. The Journal of Pediatrics, 233, 183–190.

Lertwattanachai, T., Montakantikul, P., Tangsujaritvijit, V., Sanguanwit, P., Sueajai, J., Auparakkitanon, S., et al. (2020). Clinical outcomes of empirical high-dose meropenem in critically ill patients with sepsis and septic shock: a randomized controlled trial. Journal of Intensive Care, 8, 1–10.

Busch, L. M., Kadri, S. S. (2020). Antimicrobial treatment duration in sepsis and serious infections. The Journal of Infectious Diseases, 222(Supplement_2), S142–S155.

Strich, J. R., Heil, E. L., Masur, H. (2020). Considerations for empiric antimicrobial therapy in sepsis and septic shock in an era of antimicrobial resistance. The Journal of Infectious Diseases, 222(Supplement_2), S119–S131.

Jouffroy, R., Vivien, B. (2020). Implementation of earlier antibiotic administration in patients with severe sepsis and septic shock in Japan: antibiotic action needs time and tissue perfusion to reach target. Critical Care, 24, 1–3.

Martínez, M. L., Plata-Menchaca, E. P., Ruiz-Rodríguez, J. C., Ferrer, R. (2020). An approach to antibiotic treatment in patients with sepsis. Journal of Thoracic Disease, 12(3), 1007.

Niederman, M. S., Baron, R. M., Bouadma, L., Calandra, T., Daneman, N., DeWaele, J., et al. (2021). Initial antimicrobial management of sepsis. Critical Care, 25, 1–11.

Seok, H., Song, J., Jeon, J. H., Choi, H. K., Choi, W. S., Moon, S., et al. (2020). Timing of antibiotics in septic patients: a prospective cohort study. Clinical Microbiology and Infection, 26(11), 1495–1500.

Asner, S. A., Desgranges, F., Schrijver, I. T., Calandra, T. (2021). Impact of the timeliness of antibiotic therapy on the outcome of patients with sepsis and septic shock. Journal of Infection, 82(5), 125–134.